Following strong financial results revealed last month, US-headquartered Globus Medical has agreed to acquire spinal cord stimulation (SCS) company Nevro for $250m to reinforce its position in the ...

Nevro Corp has been recognized for its differentiated high-frequency SCS offerings and solid sales base. However, the company has faced challenges in recent years, struggling with market share and ...

Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp. NVRO in an all ... placement to reduce the reliance on X-ray imaging during spine surgery. In the past year ...

95.5% of Nevro shares are held by institutional investors ... The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG ...

Market Expansion Into SI Joint Fusion: Nevro's entry into the SI joint fusion market through its acquisition of Vyrsa Technologies in December 2023 marks a strategic move to diversify beyond its ...

In addition to the U.S. market release, Nevro introduced the HFX iQ SCS system in select European countries in January 2025 following the receipt of CE Mark Certification in November 2024.

Nevro Corp has been recognized for its differentiated high-frequency SCS offerings and solid sales base. However, the company has faced challenges in recent years, struggling with market share and ...